EP Patent

EP1861361A1 — Glycopyrronium salts and their therapeutic use

Assigned to Sosei R&D Ltd · Expires 2007-12-05 · 18y expired

What this patent protects

A glycopyrronium salt such as glycopyrronium iodide has a lower glass transition temperature than glycopyrronium bromide. It is therefore more suitable for formulation.

USPTO Abstract

A glycopyrronium salt such as glycopyrronium iodide has a lower glass transition temperature than glycopyrronium bromide. It is therefore more suitable for formulation.

Drugs covered by this patent

Patent Metadata

Patent number: EP1861361A1
Jurisdiction: EP
Classification: —
Expires: 2007-12-05
Drug substance claim: No
Drug product claim: No
Assignee: Sosei R&D Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.